Swan Capital’s Oscar Health OSCR Stock Holding History

Swan Capital’s Portfolio OSCR Stock Details OSCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-80	Closed	-$1.05K	–	497
2025 Q1	$1.05K	Buy	80 +20	+33%	+$297	﹤0.01%	283
2024 Q4	$806	Buy	+60	New	+$966	﹤0.01%	295

Other funds holding OSCR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

TCMNY

Thrive Capital Management (New York) New York $344M AUM 25.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Swan Capital's OSCR Position: Q2 2025 in Review

Swan Capital sold out of Oscar Health (OSCR) in Q2 2025, closing a stake of 80 shares — an estimated $1.05K sold.

Swan Capital first reported a position in OSCR in Q4 2024 and held it in 2 quarters. The position peaked at $1.05K in Q1 2025. 332 funds tracked by Wall St. Rank hold OSCR as of Q2 2025.

Swan Capital reported no remaining Oscar Health position as of Q2 2025 after selling out during the quarter.
Swan Capital sold 80 Oscar Health shares in Q2 2025, an estimated $1.05K.
Swan Capital first reported a position in Oscar Health in Q4 2024 and held it in 2 quarters.
Swan Capital's Oscar Health position peaked at $1.05K in Q1 2025.
332 funds tracked by Wall St. Rank held Oscar Health as of Q2 2025.

Based on Swan Capital's 13F filing for Q2 2025, filed 14 Aug 2025.